McLaren Cancer Institute-Flint is a clinical research site located in Flint, Michigan, United States 48532.
Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.
McLaren Cancer Institute-Flint has participated in 80 clinical trials with 53 currently active.
Therapeutic areas: Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8.
Sponsors: Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), SWOG Cancer Research Network.
Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
McLaren Cancer Institute-Flint has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McLaren Cancer Institute-Flint has 80 clinical trials on record, with 53 currently active. Their work covers Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8.
Yes — McLaren Cancer Institute-Flint holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.